MedTrace Logo

Pediatric Second Influenza Dose Portal Reminder Recall

NCT04668417 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 698

Last updated 2021-05-28

No results posted yet for this study

Summary

This trial is taking place in Los Angeles, CA among patients from primary care practices within the UCLA Health System.

The study design is a parallel 2-arm trial. The parallel arms are 1) a reminder letter for the second dose of influenza vaccine (reminder messages sent via the patient portal) with a direct appointment scheduling link included in the reminder and 2) a reminder letter for the second dose of influenza vaccine, but no direct appointment scheduling link included.

Conditions

Interventions

BEHAVIORAL

Portal Reminders for Second Dose of Influenza Vaccine with Direct Scheduling Link

Patient proxy receives reminder/recall messages via the patient portal to get a second dose of influenza vaccine with a direct scheduling link included, enabling the patient to directly schedule a flu vaccination only visit

BEHAVIORAL

Portal Reminders for Second Dose of Influenza Vaccine without Direct Scheduling Link

Patient proxy receives reminder/recall messages via the patient portal to get a second dose of influenza vaccine with no direct scheduling link included

Sponsors & Collaborators

Principal Investigators

  • Peter G Szilagyi, MD, MPH · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
36 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-15
Primary Completion
2021-04-01
Completion
2021-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04668417 on ClinicalTrials.gov